Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Cancer cachexia.

Kern KA, Norton JA.

JPEN J Parenter Enteral Nutr. 1988 May-Jun;12(3):286-98. Review.

PMID:
3292798
2.

The syndrome of cardiac cachexia.

Anker SD, Sharma R.

Int J Cardiol. 2002 Sep;85(1):51-66. Review.

PMID:
12163209
3.

Definition and classification of cancer cachexia: an international consensus.

Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE.

Lancet Oncol. 2011 May;12(5):489-95. doi: 10.1016/S1470-2045(10)70218-7. Epub 2011 Feb 4. Review.

PMID:
21296615
4.

N-3 fatty acids, cancer and cachexia: a systematic review of the literature.

Colomer R, Moreno-Nogueira JM, García-Luna PP, García-Peris P, García-de-Lorenzo A, Zarazaga A, Quecedo L, del Llano J, Usán L, Casimiro C.

Br J Nutr. 2007 May;97(5):823-31. Review.

5.

Cancer cachexia: mediators, signaling, and metabolic pathways.

Fearon KC, Glass DJ, Guttridge DC.

Cell Metab. 2012 Aug 8;16(2):153-66. doi: 10.1016/j.cmet.2012.06.011. Epub 2012 Jul 12. Review.

6.

Myostatin is a novel tumoral factor that induces cancer cachexia.

Lokireddy S, Wijesoma IW, Bonala S, Wei M, Sze SK, McFarlane C, Kambadur R, Sharma M.

Biochem J. 2012 Aug 15;446(1):23-36. doi: 10.1042/BJ20112024. Erratum in: Biochem J. 2015 Feb 15;466(1):201. Retraction in: Lokireddy S, Wijesoma IW, Bonala S, Wei M, Sze SK, McFarlane C, Kambadur R, Sharma M. Biochem J. 2016 Apr 15;473(8):1111.

7.

Cachexia: a new definition.

Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD.

Clin Nutr. 2008 Dec;27(6):793-9. doi: 10.1016/j.clnu.2008.06.013. Epub 2008 Aug 21.

PMID:
18718696
8.

Understanding the mechanisms and treatment options in cancer cachexia.

Fearon K, Arends J, Baracos V.

Nat Rev Clin Oncol. 2013 Feb;10(2):90-9. doi: 10.1038/nrclinonc.2012.209. Epub 2012 Dec 4. Review.

PMID:
23207794
9.

Mechanisms of cancer cachexia.

Tisdale MJ.

Physiol Rev. 2009 Apr;89(2):381-410. doi: 10.1152/physrev.00016.2008. Review.

PMID:
19342610
10.

Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".

Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Fearon KC, Laviano A, Maggio M, Rossi Fanelli F, Schneider SM, Schols A, Sieber CC.

Clin Nutr. 2010 Apr;29(2):154-9. doi: 10.1016/j.clnu.2009.12.004. Epub 2010 Jan 8.

PMID:
20060626
11.

Cancer cachexia: from molecular mechanisms to patient's care.

Lucia S, Esposito M, Rossi Fanelli F, Muscaritoli M.

Crit Rev Oncog. 2012;17(3):315-21. Review.

PMID:
22831162
12.

Zinc as an appetite stimulator - the possible role of zinc in the progression of diseases such as cachexia and sarcopenia.

Suzuki H, Asakawa A, Li JB, Tsai M, Amitani H, Ohinata K, Komai M, Inui A.

Recent Pat Food Nutr Agric. 2011 Sep;3(3):226-31. Review.

PMID:
21846317
13.

Multitargeted treatment of cancer cachexia.

Madeddu C, Maccio A, Mantovani G.

Crit Rev Oncog. 2012;17(3):305-14. Review.

PMID:
22831161
14.

Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.

Zhou X, Wang JL, Lu J, Song Y, Kwak KS, Jiao Q, Rosenfeld R, Chen Q, Boone T, Simonet WS, Lacey DL, Goldberg AL, Han HQ.

Cell. 2010 Aug 20;142(4):531-43. doi: 10.1016/j.cell.2010.07.011.

15.

Cachexia versus sarcopenia.

Rolland Y, Abellan van Kan G, Gillette-Guyonnet S, Vellas B.

Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):15-21. doi: 10.1097/MCO.0b013e328340c2c2. Review.

PMID:
21076295
16.

The use of herbal medicine in cancer-related anorexia/ cachexia treatment around the world.

Cheng KC, Li YX, Cheng JT.

Curr Pharm Des. 2012;18(31):4819-26. Review.

PMID:
22632862
17.

Nutritional support in multimodal therapy for cancer cachexia.

Bosaeus I.

Support Care Cancer. 2008 May;16(5):447-51. doi: 10.1007/s00520-007-0388-7. Epub 2008 Jan 15. Review.

PMID:
18196284
18.

Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.

Garcia JM, Friend J, Allen S.

Support Care Cancer. 2013 Jan;21(1):129-37. doi: 10.1007/s00520-012-1500-1. Epub 2012 Jun 16.

PMID:
22699302
19.

JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.

Bonetto A, Aydogdu T, Jin X, Zhang Z, Zhan R, Puzis L, Koniaris LG, Zimmers TA.

Am J Physiol Endocrinol Metab. 2012 Aug 1;303(3):E410-21. doi: 10.1152/ajpendo.00039.2012. Epub 2012 Jun 5.

20.

Nutritional interventions for cancer-induced cachexia.

Gullett NP, Mazurak VC, Hebbar G, Ziegler TR.

Curr Probl Cancer. 2011 Mar-Apr;35(2):58-90. doi: 10.1016/j.currproblcancer.2011.01.001. No abstract available.

Supplemental Content

Support Center